1 Introduction to Research & Analysis Reports
1.1 Molecular Diagnosis of Clostridium Difficile Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Molecular Diagnosis of Clostridium Difficile Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Molecular Diagnosis of Clostridium Difficile Overall Market Size
2.1 Global Molecular Diagnosis of Clostridium Difficile Market Size: 2022 VS 2029
2.2 Global Molecular Diagnosis of Clostridium Difficile Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Molecular Diagnosis of Clostridium Difficile Sales: 2018-2029
3 Company Landscape
3.1 Top Molecular Diagnosis of Clostridium Difficile Players in Global Market
3.2 Top Global Molecular Diagnosis of Clostridium Difficile Companies Ranked by Revenue
3.3 Global Molecular Diagnosis of Clostridium Difficile Revenue by Companies
3.4 Global Molecular Diagnosis of Clostridium Difficile Sales by Companies
3.5 Global Molecular Diagnosis of Clostridium Difficile Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Molecular Diagnosis of Clostridium Difficile Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Molecular Diagnosis of Clostridium Difficile Product Type
3.8 Tier 1, Tier 2 and Tier 3 Molecular Diagnosis of Clostridium Difficile Players in Global Market
3.8.1 List of Global Tier 1 Molecular Diagnosis of Clostridium Difficile Companies
3.8.2 List of Global Tier 2 and Tier 3 Molecular Diagnosis of Clostridium Difficile Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Molecular Diagnosis of Clostridium Difficile Market Size Markets, 2022 & 2029
4.1.2 Sensitivity Above 90%
4.1.3 Sensitivity Below 90%
4.2 By Type – Global Molecular Diagnosis of Clostridium Difficile Revenue & Forecasts
4.2.1 By Type – Global Molecular Diagnosis of Clostridium Difficile Revenue, 2018-2023
4.2.2 By Type – Global Molecular Diagnosis of Clostridium Difficile Revenue, 2024-2029
4.2.3 By Type – Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share, 2018-2029
4.3 By Type – Global Molecular Diagnosis of Clostridium Difficile Sales & Forecasts
4.3.1 By Type – Global Molecular Diagnosis of Clostridium Difficile Sales, 2018-2023
4.3.2 By Type – Global Molecular Diagnosis of Clostridium Difficile Sales, 2024-2029
4.3.3 By Type – Global Molecular Diagnosis of Clostridium Difficile Sales Market Share, 2018-2029
4.4 By Type – Global Molecular Diagnosis of Clostridium Difficile Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Molecular Diagnosis of Clostridium Difficile Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Laboratory
5.1.5 Home Care
5.1.6 Others
5.2 By Application – Global Molecular Diagnosis of Clostridium Difficile Revenue & Forecasts
5.2.1 By Application – Global Molecular Diagnosis of Clostridium Difficile Revenue, 2018-2023
5.2.2 By Application – Global Molecular Diagnosis of Clostridium Difficile Revenue, 2024-2029
5.2.3 By Application – Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share, 2018-2029
5.3 By Application – Global Molecular Diagnosis of Clostridium Difficile Sales & Forecasts
5.3.1 By Application – Global Molecular Diagnosis of Clostridium Difficile Sales, 2018-2023
5.3.2 By Application – Global Molecular Diagnosis of Clostridium Difficile Sales, 2024-2029
5.3.3 By Application – Global Molecular Diagnosis of Clostridium Difficile Sales Market Share, 2018-2029
5.4 By Application – Global Molecular Diagnosis of Clostridium Difficile Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Molecular Diagnosis of Clostridium Difficile Market Size, 2022 & 2029
6.2 By Region – Global Molecular Diagnosis of Clostridium Difficile Revenue & Forecasts
6.2.1 By Region – Global Molecular Diagnosis of Clostridium Difficile Revenue, 2018-2023
6.2.2 By Region – Global Molecular Diagnosis of Clostridium Difficile Revenue, 2024-2029
6.2.3 By Region – Global Molecular Diagnosis of Clostridium Difficile Revenue Market Share, 2018-2029
6.3 By Region – Global Molecular Diagnosis of Clostridium Difficile Sales & Forecasts
6.3.1 By Region – Global Molecular Diagnosis of Clostridium Difficile Sales, 2018-2023
6.3.2 By Region – Global Molecular Diagnosis of Clostridium Difficile Sales, 2024-2029
6.3.3 By Region – Global Molecular Diagnosis of Clostridium Difficile Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Molecular Diagnosis of Clostridium Difficile Revenue, 2018-2029
6.4.2 By Country – North America Molecular Diagnosis of Clostridium Difficile Sales, 2018-2029
6.4.3 US Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.4.4 Canada Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.4.5 Mexico Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Molecular Diagnosis of Clostridium Difficile Revenue, 2018-2029
6.5.2 By Country – Europe Molecular Diagnosis of Clostridium Difficile Sales, 2018-2029
6.5.3 Germany Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.5.4 France Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.5.5 U.K. Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.5.6 Italy Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.5.7 Russia Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.5.8 Nordic Countries Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.5.9 Benelux Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Molecular Diagnosis of Clostridium Difficile Revenue, 2018-2029
6.6.2 By Region – Asia Molecular Diagnosis of Clostridium Difficile Sales, 2018-2029
6.6.3 China Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.6.4 Japan Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.6.5 South Korea Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.6.6 Southeast Asia Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.6.7 India Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Molecular Diagnosis of Clostridium Difficile Revenue, 2018-2029
6.7.2 By Country – South America Molecular Diagnosis of Clostridium Difficile Sales, 2018-2029
6.7.3 Brazil Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.7.4 Argentina Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Molecular Diagnosis of Clostridium Difficile Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Molecular Diagnosis of Clostridium Difficile Sales, 2018-2029
6.8.3 Turkey Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.8.4 Israel Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.8.5 Saudi Arabia Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
6.8.6 UAE Molecular Diagnosis of Clostridium Difficile Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Molecular Diagnosis of Clostridium Difficile Major Product Offerings
7.1.4 Roche Molecular Diagnosis of Clostridium Difficile Sales and Revenue in Global (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Thermo Scientific
7.2.1 Thermo Scientific Company Summary
7.2.2 Thermo Scientific Business Overview
7.2.3 Thermo Scientific Molecular Diagnosis of Clostridium Difficile Major Product Offerings
7.2.4 Thermo Scientific Molecular Diagnosis of Clostridium Difficile Sales and Revenue in Global (2018-2023)
7.2.5 Thermo Scientific Key News & Latest Developments
7.3 Cepheid (Danaher)
7.3.1 Cepheid (Danaher) Company Summary
7.3.2 Cepheid (Danaher) Business Overview
7.3.3 Cepheid (Danaher) Molecular Diagnosis of Clostridium Difficile Major Product Offerings
7.3.4 Cepheid (Danaher) Molecular Diagnosis of Clostridium Difficile Sales and Revenue in Global (2018-2023)
7.3.5 Cepheid (Danaher) Key News & Latest Developments
7.4 BD
7.4.1 BD Company Summary
7.4.2 BD Business Overview
7.4.3 BD Molecular Diagnosis of Clostridium Difficile Major Product Offerings
7.4.4 BD Molecular Diagnosis of Clostridium Difficile Sales and Revenue in Global (2018-2023)
7.4.5 BD Key News & Latest Developments
7.5 Meridian
7.5.1 Meridian Company Summary
7.5.2 Meridian Business Overview
7.5.3 Meridian Molecular Diagnosis of Clostridium Difficile Major Product Offerings
7.5.4 Meridian Molecular Diagnosis of Clostridium Difficile Sales and Revenue in Global (2018-2023)
7.5.5 Meridian Key News & Latest Developments
7.6 TECHLAB
7.6.1 TECHLAB Company Summary
7.6.2 TECHLAB Business Overview
7.6.3 TECHLAB Molecular Diagnosis of Clostridium Difficile Major Product Offerings
7.6.4 TECHLAB Molecular Diagnosis of Clostridium Difficile Sales and Revenue in Global (2018-2023)
7.6.5 TECHLAB Key News & Latest Developments
7.7 Luminex
7.7.1 Luminex Company Summary
7.7.2 Luminex Business Overview
7.7.3 Luminex Molecular Diagnosis of Clostridium Difficile Major Product Offerings
7.7.4 Luminex Molecular Diagnosis of Clostridium Difficile Sales and Revenue in Global (2018-2023)
7.7.5 Luminex Key News & Latest Developments
7.8 CerTest Biotec
7.8.1 CerTest Biotec Company Summary
7.8.2 CerTest Biotec Business Overview
7.8.3 CerTest Biotec Molecular Diagnosis of Clostridium Difficile Major Product Offerings
7.8.4 CerTest Biotec Molecular Diagnosis of Clostridium Difficile Sales and Revenue in Global (2018-2023)
7.8.5 CerTest Biotec Key News & Latest Developments
7.9 Quidel
7.9.1 Quidel Company Summary
7.9.2 Quidel Business Overview
7.9.3 Quidel Molecular Diagnosis of Clostridium Difficile Major Product Offerings
7.9.4 Quidel Molecular Diagnosis of Clostridium Difficile Sales and Revenue in Global (2018-2023)
7.9.5 Quidel Key News & Latest Developments
7.10 Zhejiang Orient Gene Biotech
7.10.1 Zhejiang Orient Gene Biotech Company Summary
7.10.2 Zhejiang Orient Gene Biotech Business Overview
7.10.3 Zhejiang Orient Gene Biotech Molecular Diagnosis of Clostridium Difficile Major Product Offerings
7.10.4 Zhejiang Orient Gene Biotech Molecular Diagnosis of Clostridium Difficile Sales and Revenue in Global (2018-2023)
7.10.5 Zhejiang Orient Gene Biotech Key News & Latest Developments
7.11 Beijing Promed Medical Technology
7.11.1 Beijing Promed Medical Technology Company Summary
7.11.2 Beijing Promed Medical Technology Molecular Diagnosis of Clostridium Difficile Business Overview
7.11.3 Beijing Promed Medical Technology Molecular Diagnosis of Clostridium Difficile Major Product Offerings
7.11.4 Beijing Promed Medical Technology Molecular Diagnosis of Clostridium Difficile Sales and Revenue in Global (2018-2023)
7.11.5 Beijing Promed Medical Technology Key News & Latest Developments
7.12 Jiangsu Besthree Biotechnology
7.12.1 Jiangsu Besthree Biotechnology Company Summary
7.12.2 Jiangsu Besthree Biotechnology Molecular Diagnosis of Clostridium Difficile Business Overview
7.12.3 Jiangsu Besthree Biotechnology Molecular Diagnosis of Clostridium Difficile Major Product Offerings
7.12.4 Jiangsu Besthree Biotechnology Molecular Diagnosis of Clostridium Difficile Sales and Revenue in Global (2018-2023)
7.12.5 Jiangsu Besthree Biotechnology Key News & Latest Developments
8 Global Molecular Diagnosis of Clostridium Difficile Production Capacity, Analysis
8.1 Global Molecular Diagnosis of Clostridium Difficile Production Capacity, 2018-2029
8.2 Molecular Diagnosis of Clostridium Difficile Production Capacity of Key Manufacturers in Global Market
8.3 Global Molecular Diagnosis of Clostridium Difficile Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Molecular Diagnosis of Clostridium Difficile Supply Chain Analysis
10.1 Molecular Diagnosis of Clostridium Difficile Industry Value Chain
10.2 Molecular Diagnosis of Clostridium Difficile Upstream Market
10.3 Molecular Diagnosis of Clostridium Difficile Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Molecular Diagnosis of Clostridium Difficile Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
世界のクロストリジウム・ディフィシル腸炎用分子診断市場予測2023-2029：感度90%以上、感度90%以下 |
| 【英語タイトル】Molecular Diagnosis of Clostridium Difficile Market, Global Outlook and Forecast 2023-2029 | |
 | ・商品コード：MMG23JU5312 ・発行会社（調査会社）：Market Monitor Global ・発行日：2023年6月 ・ページ数：77 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後2-3営業日） ・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど ・産業分野：医療機器＆消耗品 |
| Single User（1名様閲覧用） | USD3,250 ⇒換算￥494,000 | 見積依頼/購入/質問フォーム |
| Multi User（20名様閲覧用） | USD4,225 ⇒換算￥642,200 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数制限なし） | USD4,875 ⇒換算￥741,000 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| 当調査レポートは次の情報を含め、世界のクロストリジウム・ディフィシル腸炎用分子診断市場規模と予測を収録しています。・世界のクロストリジウム・ディフィシル腸炎用分子診断市場：売上、2018年-2023年、2024年-2029年 ・世界のクロストリジウム・ディフィシル腸炎用分子診断市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界のクロストリジウム・ディフィシル腸炎用分子診断市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「感度90%以上」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 クロストリジウム・ディフィシル腸炎用分子診断のグローバル主要企業は、Roche、 Thermo Scientific、 Cepheid (Danaher)、 BD、 Meridian、 TECHLAB、 Luminex、 CerTest Biotec、 Quidel、 Zhejiang Orient Gene Biotech、 Beijing Promed Medical Technology、 Jiangsu Besthree Biotechnologyなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、クロストリジウム・ディフィシル腸炎用分子診断のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界のクロストリジウム・ディフィシル腸炎用分子診断市場：タイプ別、2018年-2023年、2024年-2029年 世界のクロストリジウム・ディフィシル腸炎用分子診断市場：タイプ別市場シェア、2022年 ・感度90%以上、感度90%以下 世界のクロストリジウム・ディフィシル腸炎用分子診断市場：用途別、2018年-2023年、2024年-2029年 世界のクロストリジウム・ディフィシル腸炎用分子診断市場：用途別市場シェア、2022年 ・病院、診療所、検査室、在宅医療、その他 世界のクロストリジウム・ディフィシル腸炎用分子診断市場：地域・国別、2018年-2023年、2024年-2029年 世界のクロストリジウム・ディフィシル腸炎用分子診断市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業におけるクロストリジウム・ディフィシル腸炎用分子診断のグローバル売上、2018年-2023年 ・主要企業におけるクロストリジウム・ディフィシル腸炎用分子診断のグローバル売上シェア、2022年 ・主要企業におけるクロストリジウム・ディフィシル腸炎用分子診断のグローバル販売量、2018年-2023年 ・主要企業におけるクロストリジウム・ディフィシル腸炎用分子診断のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Roche、 Thermo Scientific、 Cepheid (Danaher)、 BD、 Meridian、 TECHLAB、 Luminex、 CerTest Biotec、 Quidel、 Zhejiang Orient Gene Biotech、 Beijing Promed Medical Technology、 Jiangsu Besthree Biotechnology ************************************************************* ・調査・分析レポートの概要 クロストリジウム・ディフィシル腸炎用分子診断市場の定義 市場セグメント 世界のクロストリジウム・ディフィシル腸炎用分子診断市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界のクロストリジウム・ディフィシル腸炎用分子診断市場規模 世界のクロストリジウム・ディフィシル腸炎用分子診断市場規模：2022年 VS 2029年 世界のクロストリジウム・ディフィシル腸炎用分子診断市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでのクロストリジウム・ディフィシル腸炎用分子診断の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業のクロストリジウム・ディフィシル腸炎用分子診断製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：感度90%以上、感度90%以下 クロストリジウム・ディフィシル腸炎用分子診断のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、検査室、在宅医療、その他 クロストリジウム・ディフィシル腸炎用分子診断の用途別グローバル売上・予測 ・地域別市場分析 地域別クロストリジウム・ディフィシル腸炎用分子診断市場規模 2022年と2029年 地域別クロストリジウム・ディフィシル腸炎用分子診断売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Roche、 Thermo Scientific、 Cepheid (Danaher)、 BD、 Meridian、 TECHLAB、 Luminex、 CerTest Biotec、 Quidel、 Zhejiang Orient Gene Biotech、 Beijing Promed Medical Technology、 Jiangsu Besthree Biotechnology ... |
Clostridium difficile infection (CDI) is one of the most important causes of nosocomial diarrhoea and is also becoming important in the community and in populations with low or no risk factors.Especially during outbreaks and during the spread of strains with increased virulence it is important that the laboratory diagnosis is rapid and sensitive to ensure appropriate therapy and quick implementation of hospital hygiene measures.Therefore, the improvement of diagnostic methods is becoming more and more important.
This report aims to provide a comprehensive presentation of the global market for Molecular Diagnosis of Clostridium Difficile, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Molecular Diagnosis of Clostridium Difficile. This report contains market size and forecasts of Molecular Diagnosis of Clostridium Difficile in global, including the following market information:
Global Molecular Diagnosis of Clostridium Difficile Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Molecular Diagnosis of Clostridium Difficile Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Molecular Diagnosis of Clostridium Difficile companies in 2022 (%)
The global Molecular Diagnosis of Clostridium Difficile market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Sensitivity Above 90% Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Molecular Diagnosis of Clostridium Difficile include Roche, Thermo Scientific, Cepheid (Danaher), BD, Meridian, TECHLAB, Luminex, CerTest Biotec and Quidel, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Molecular Diagnosis of Clostridium Difficile manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Molecular Diagnosis of Clostridium Difficile Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Molecular Diagnosis of Clostridium Difficile Market Segment Percentages, by Type, 2022 (%)
Sensitivity Above 90%
Sensitivity Below 90%
Global Molecular Diagnosis of Clostridium Difficile Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Molecular Diagnosis of Clostridium Difficile Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Laboratory
Home Care
Others
Global Molecular Diagnosis of Clostridium Difficile Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Molecular Diagnosis of Clostridium Difficile Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Molecular Diagnosis of Clostridium Difficile revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Molecular Diagnosis of Clostridium Difficile revenues share in global market, 2022 (%)
Key companies Molecular Diagnosis of Clostridium Difficile sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Molecular Diagnosis of Clostridium Difficile sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Thermo Scientific
Cepheid (Danaher)
BD
Meridian
TECHLAB
Luminex
CerTest Biotec
Quidel
Zhejiang Orient Gene Biotech
Beijing Promed Medical Technology
Jiangsu Besthree Biotechnology
Outline of Major Chapters:
Chapter 1: Introduces the definition of Molecular Diagnosis of Clostridium Difficile, market overview.
Chapter 2: Global Molecular Diagnosis of Clostridium Difficile market size in revenue and volume.
Chapter 3: Detailed analysis of Molecular Diagnosis of Clostridium Difficile manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Molecular Diagnosis of Clostridium Difficile in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Molecular Diagnosis of Clostridium Difficile capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
❖ レポートの目次 ❖
| ★調査レポート[世界のクロストリジウム・ディフィシル腸炎用分子診断市場予測2023-2029：感度90%以上、感度90%以下] (コード：MMG23JU5312)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界のクロストリジウム・ディフィシル腸炎用分子診断市場予測2023-2029：感度90%以上、感度90%以下]についてメールでお問い合わせ |
